The abstract is read at the publisher; the summary is JClub's.
Intensive blood pressure lowering in adults with and without chronic kidney disease reduces major cardiovascular events by 15% per 10-mm Hg lower achieved systolic BP.
- Why it matters: Uncertainty remains about whether intensive BP targets change cardiovascular risk and kidney outcomes differently in people with CKD versus those without.
- What they did: A systematic review and meta-analysis of 27 randomized trials (88,830 participants) compared intensive versus standard BP, standardizing effects by the between-group achieved systolic BP difference and testing CKD effect modification.
- The result: Intensive lowering lowered cardiovascular events by 4.3 (SE 1.2) per 1000 person-years in CKD and 2.7 (SE 0.4) in non-CKD, did not change kidney failure risk (RR 0.97; 95% CI 0.84-1.11), but increased sustained eGFR decline risks (RR 1.42 and 1.47).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.